US Stock MarketDetailed Quotes

RGLS Regulus Therapeutics

Watchlist

1.4600
+0.0600+4.29%

Trading Nov 22 14:33 ET

95.63MMarket Cap-1431P/E (TTM)

Regulus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regulus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Regulus Therapeutics Earnings Reports

Regulus Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 16:33 ET

Regulus Therapeutics | 8-K: Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates

Nov 7 16:22 ET

Regulus Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 16:30 ET

Regulus Therapeutics | 8-K: Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates

Aug 8 16:24 ET

Analyst Rating

Updated: Nov 22, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall